Joy Melnikow, M.D., M.P.H.

University of California, Davis
email: jamelnikow@ucdavis.edu

Grants

Cost-effectiveness Analysis to Inform BC Screening Policy 2011 (Cycle 17)
IDEA (Innovative, Developmental, and Exploratory Awards) 17IB-0007 $149,996
Tamoxifen Prevention: Is it Acceptable to Women at Risk? 1999 (Cycle V)
RFA (Request for Applications) 5PB-0110 $321,373


Preferences of Women Evaluating Risk of Tamoxifen (Power) Study of Preferences for Tomoxifen for Breast Cancer Risk Reduction
  Periodical: Cancer
  Author(s): Melnikow J, Paterniti D, et al, Henderson S
  Yr: 2005 Vol: 103 Nbr: 10 Pgs: 1996-2005
  Associated Grant: Tamoxifen Prevention: Is it Acceptable to Women at Risk?